Literature DB >> 24958081

Prevention: Aspirin in primary prevention needs individual judgements.

Charles H Hennekens1, David L DeMets2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24958081     DOI： 10.1038/nrcardio.2014.88

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  9 in total

1.  Global risk assessment for cardiovascular disease and astute clinical judgement.

Authors:  Charles H Hennekens; Ralph B D'Agostino
Journal:  Eur Heart J       Date:  2003-11       Impact factor: 29.983

2.  Statistical association and causation: contributions of different types of evidence.

Authors:  Charles H Hennekens; David DeMets
Journal:  JAMA       Date:  2011-03-16       Impact factor: 56.272

Review 3.  Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors.

Authors:  C H Hennekens
Journal:  Circulation       Date:  1998-03-24       Impact factor: 29.690

4.  Prevention. Aspirin in primary prevention--good news and bad news.

Authors:  Charles H Hennekens; Colin Baigent
Journal:  Nat Rev Cardiol       Date:  2012-02-28       Impact factor: 32.419

5.  Utilization of statins: guiding principles and the new United States guidelines.

Authors:  Charles H Hennekens; Ira J Gelb
Journal:  Cardiology       Date:  2014-02-08       Impact factor: 1.869

6.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

7.  Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis.

Authors:  Michael D Miedema; Daniel A Duprez; Jeffrey R Misialek; Michael J Blaha; Khurram Nasir; Michael G Silverman; Ron Blankstein; Matthew J Budoff; Philip Greenland; Aaron R Folsom
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-05-06

8.  Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.

Authors:  Charles H Hennekens; Frank M Sacks; Andrew Tonkin; J Wouter Jukema; Robert P Byington; Bertram Pitt; Donald A Berry; Scott M Berry; Neville F Ford; Andrew J Walker; Kannan Natarajan; Chen Sheng-Lin; Frederick T Fiedorek; Rene Belder
Journal:  Arch Intern Med       Date:  2004-01-12

9.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321
  9 in total
  4 in total

1.  Association between Aspirin Therapy and Clinical Outcomes in Patients with Non-Obstructive Coronary Artery Disease: A Cohort Study.

Authors:  In-Chang Hwang; Joo-Yeong Jeon; Younhee Kim; Hyue Mee Kim; Yeonyee E Yoon; Seung-Pyo Lee; Hyung-Kwan Kim; Dae-Won Sohn; Jidong Sung; Yong-Jin Kim
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

Review 2.  Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.

Authors:  Luis A García Rodríguez; Mar Martín-Pérez; Charles H Hennekens; Peter M Rothwell; Angel Lanas
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

Review 3.  Aspirin for primary prevention of cardiovascular disease.

Authors:  Jobert Richie N Nansseu; Jean Jacques N Noubiap
Journal:  Thromb J       Date:  2015-12-04

4.  Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit-risk ratio, not age.

Authors:  Kyungmann Kim; Charles H Hennekens; Lisa Martinez; J Michael Gaziano; Marc A Pfeffer; Bianca Biglione; Alexander Gitin; Jeanne Bell McCabe; Thomas D Cook; David L DeMets; Sarah K Wood
Journal:  Fam Med Community Health       Date:  2021-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.